Botanical species · safety record

Lythrum salicaria

The EFSA Compendium of Botanicals holds 8 constituent measurements and 1 genotoxicity assay for Lythrum salicaria. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Lythrum salicaria L.

8Constituent measurements

1Safety records

5Cited sources

1Licensed products (Canada)

Also recorded as

Lythrum anceps (Koehne) Makino
Lythrum salicaria var. tomentosum (Mill.) DC.

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 1 licensed products naming Lythrum salicaria as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

Herb

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Isoquinoline alkaloids	Unspecified	Solvent extraction	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	No resolvable identifier
Peucedanin	Aerial part of plants	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Saponins	Live plants	—	—	Unspecified	No resolvable identifier
Tannins	Live plants	—	—	Unspecified	No resolvable identifier
Tannins	Flower	—	13.7 Percent	Unspecified	No resolvable identifier
Tannins	Leaves	—	12 Percent	Unspecified	No resolvable identifier
Tannins	Roots and other underground parts	—	8.5 Percent	Unspecified	No resolvable identifier
Tannins	Stem / stalk	—	10.5 Percent	Unspecified	No resolvable identifier

Genotoxicity testing

Outcomes of genotoxicity assays as recorded in the source. A negative assay is a result under those test conditions, not a clearance.

Outcome	Endpoint	Test	Tested organism	Metabolic activation	Source
Positive	DNA damage and/or repair	micronucleus assay	Other	No data	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Aynehchi, Y., Sormaghi, M. H. Salehi., Amin, G. H., Soltani, A., Qumehr, N. Survey of Iranian plants for saponins, alkaloids, flavonoids and tannins. II. International Journal of Crude Drug Research, 1982, p. 61-70.
Eck-Varanka, Bettina., Kovats, Nora., Hubai, Katalin., Paulovits, Gabor., Ferincz, Arpad., Horvath, Eszter. GENOTOXIC EFFECT OF LYTHRUM SALICARIA EXTRACT DETERMINED BY THE MUSSEL MICRONUCLEUS TEST . Acta biologica hungarica, 2015, vol. 66, no. 4, p. 460-463. DOI
Fujita, E., Saeki, Y. Lythraceous alkaloids. VIII. Mass spectra of lythrancine and lythrancepine alkaloids. Journal of the chemical society, perkin transactions 1: organic and bio-organic chemistry, None, p. 301-305.
Manayi, Azadeh., Saeidnia, Soodabeh., Ostad, Seyed Nasser., Hadjiakhoondi, Abbas., Ardekani, Mohammad Reza Shams., Vazirian, Mahdi., Akhtar, Yasmin., Khanavi, Mahnaz. Chemical Constituents and Cytotoxic Effect of the Main Compounds of Lythrum salicaria L. . Zeitschrift fur naturforschung section c-a journal of biosciences, 2013, vol. 68, no. 9-10, p. 367-375.
Paris, Michel. Biochemical study of loosestrife (Lythrum salicaria), especially polyphenols. Travaux des laboratoires de matiere medicale et de pharmacie galenique des facultes de pharmacie de paris, 1968, p. I/1-111.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature